A new trading day began on Monday, with Structure Therapeutics Inc ADR (NASDAQ: GPCR) stock price down -5.36% from the previous day of trading, before settling in for the closing price of $15.12. GPCR’s price has ranged from $14.88 to $62.74 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 6.55%. With a float of $54.47 million, this company’s outstanding shares have now reached $57.29 million.
Let’s determine the extent of company efficiency that accounts for 163 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Structure Therapeutics Inc ADR (GPCR) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Structure Therapeutics Inc ADR is 4.91%, while institutional ownership is 102.77%.
Structure Therapeutics Inc ADR (GPCR) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -25.24% during the next five years compared to -51.75% drop over the previous five years of trading.
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Trading Performance Indicators
Here are Structure Therapeutics Inc ADR’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 24.74.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.32, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -1.46 in one year’s time.
Technical Analysis of Structure Therapeutics Inc ADR (GPCR)
Looking closely at Structure Therapeutics Inc ADR (NASDAQ: GPCR), its last 5-days average volume was 1.22 million, which is a jump from its year-to-date volume of 0.83 million. As of the previous 9 days, the stock’s Stochastic %D was 9.37%. Additionally, its Average True Range was 1.65.
During the past 100 days, Structure Therapeutics Inc ADR’s (GPCR) raw stochastic average was set at 2.20%, which indicates a significant decrease from 5.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.43% in the past 14 days, which was higher than the 80.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $22.83, while its 200-day Moving Average is $32.93. However, in the short run, Structure Therapeutics Inc ADR’s stock first resistance to watch stands at $15.32. Second resistance stands at $16.32. The third major resistance level sits at $17.12. If the price goes on to break the first support level at $13.52, it is likely to go to the next support level at $12.72. Now, if the price goes above the second support level, the third support stands at $11.72.
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Key Stats
With a market capitalization of 819.82 million, the company has a total of 57,343K Shares Outstanding. Currently, annual sales are 0 K while annual income is -122,530 K. The company’s previous quarter sales were 0 K while its latest quarter income was -36,480 K.
